Application of cashew nut membrane extract to preparation of hair care composition

A hair care composition prepared using cashew nut membrane extract addresses the shortcomings of existing hair care products in terms of hair follicle health and hair loss, achieving the effects of enhancing hair follicle health and promoting hair growth.

CN118985906APending Publication Date: 2024-11-22BIOFUNCTION SHANGHAI BIOTECH GRP
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202410639225.5
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Priority Date
2023-05-22
Filing Date
2024-05-22
Publication Date
2024-11-22

AI Technical Summary

Technical Problem

There is room for improvement in existing hair care products in meeting consumer needs, particularly in the lack of effective natural ingredients to promote hair follicle health and reduce hair loss.

Method used

By using cashew membrane extract, the cashew membrane is extracted with a solvent to prepare a hair care composition containing compounds such as epicatechin coumarate, phloroglucinol, protocatechuic acid and naringenin 7-O-(6”-O-p-coumaryl)-β-D-glucoside, which improves hair follicle health and antioxidant capacity.

Benefits of technology

It enhances the antioxidant capacity of hair follicle cells, promotes angiogenesis in hair follicles, reduces the expression of hair loss genes, increases hair diameter, promotes hair growth, and improves hair follicle health and hair quality.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118985906A_ABST
    Figure CN118985906A_ABST
Patent Text Reader

Abstract

The invention relates to an application of a cashew nut membrane extract, which is used for preparing a hair health care composition. Wherein the cashew nut membrane extract is obtained by extracting a fruit membrane of a cashew nut (Anacardium occidentale) by using a solvent.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the application of cashew nut, and particularly relates to the application of cashew nut membrane extract in preparing a hair health care composition. Background Art

[0002] Since the rise of the concept of organic and / or natural diets, biotech companies and food companies have actively invested in the research and development of natural plant-related products. In order to provide a scientific basis for the health benefits of plant-related products, the analysis of plant active ingredients and efficacy evaluation have become key projects in product development.

[0003] Cashew (Anacardium occidentale) is a popular nut. The cashew tree is native to northern Brazil and is now cultivated in many tropical and subtropical regions, such as Vietnam. Cashews are rich in nutritional value. Cashew kernels are rich in unsaturated fatty acids, especially monounsaturated fatty acids such as oleic acid. In addition, cashews also contain nutrients such as vitamin E, vitamin K, vitamin B6, calcium, magnesium, potassium and antioxidants. Summary of the invention

[0004] In the field of hair health care, people pay more and more attention to obtaining necessary nutrients from diet to promote the health of scalp and hair. Although there are many care products on the market, and people are increasingly aware of the impact of nutrition in diet on hair, the relevant products on the market still have room for improvement in meeting consumer needs. Therefore, hair-related products have attracted the attention and favor of consumers. Therefore, the inventor actively researches and develops the application of cashew nuts in hair-related products.

[0005] In some embodiments, a cashew nut membrane extract is used for preparing a hair care composition. The cashew nut membrane extract is prepared by extracting cashew nut membrane with a solvent.

[0006] In some embodiments, in the extraction step, the solid-liquid ratio of the cashew nut membrane to water is 5 to 20: 1 to 5, the extraction temperature is 80° C. to 90° C., and the extraction time is 80 minutes to 120 minutes.

[0007] In some embodiments, cashew nut membrane extract has the ability to increase hair follicle health.

[0008] In some embodiments, the cashew nut membrane extract increases hair follicle health by enhancing the antioxidant capacity of hair follicle cells.

[0009] In some embodiments, the cashew nut membrane extract increases hair follicle health by promoting hair follicle cell proliferation.

[0010] In some embodiments, the cashew nut membrane extract is at least one compound selected from the group consisting of epicatechin coumarate, phloroglucinol, protocatechuic acid, and naringenin 7-O-(6″-O-p-coumaryl)-β-D-glucoside.

[0011] In some embodiments, the cashew nut membrane extract increases hair follicle health by increasing hair follicle angiogenesis.

[0012] In some embodiments, cashew nut membrane extract increases hair follicle health by promoting hair growth gene expression.

[0013] In some embodiments, cashew nut membrane extract increases hair follicle health by reducing the expression of hair loss genes.

[0014] In some embodiments, cashew nut membrane extract increases the health of hair follicles by reducing blood MDA concentrations.

[0015] In some embodiments, cashew nut membrane extract has the ability to increase hair diameter.

[0016] In summary, according to any embodiment, the cashew nut membrane extract can be used to prepare a hair care composition. In other words, when the prepared hair care composition is applied to an individual, the hair care composition can improve or enhance the health of the hair on the individual, that is, the aforementioned hair care composition has the function of hair care. In some embodiments, the cashew nut membrane extract also has one or more of the following abilities: improving the antioxidant capacity of hair follicle cells, increasing hair follicle angiogenesis, promoting the expression of hair growth genes, reducing the expression of hair loss genes, and increasing hair diameter. BRIEF DESCRIPTION OF THE DRAWINGS

[0017] Figure 1 Flow chart of compound separation of cashew nut membrane extract.

[0018] Figure 2 This is the hydrogen-NMR spectrum of gallic acid.

[0019] Figure 3 This is the hydrogen-nuclear magnetic resonance spectrum of epigallocatechin gallate.

[0020] Figure 4 This is the hydrogen-nuclear magnetic resonance spectrum of epicatechin gallate.

[0021] Figure 5 This is the hydrogen-NMR spectrum of epicatechin coumarate.

[0022] Figure 6 This is the hydrogen-nuclear magnetic resonance spectrum of phloroglucinol.

[0023] Figure 7 This is the hydrogen-nuclear magnetic resonance spectrum of protocatechuic acid.

[0024] Figure 8 This is the hydrogen-nuclear magnetic resonance spectrum of naringenin 7-O-(6”-O-p-coumaryl)-β-D-glucoside.

[0025] Fig. 9 Bar graph showing the results of cell experiments on the relative ROS generation of cashew nut membrane extract.

[0026] Fig.10 This is a bar graph showing the results of cell experiments on the relative ROS generation of cashew nut membrane extract and its compounds.

[0027] Fig.11 The bar graph shows the cell experiment results of the relative cell proliferation rate of cashew nut membrane extract.

[0028] Fig.12 The bar graph shows the cell experiment results of cashew nut membrane extract and its compounds on the relative cell proliferation rate.

[0029] Fig.13 The bar graph shows the cell experiment results of the relative gene expression level (6 hours) of cashew nut membrane extract.

[0030] Fig.14 The bar graph shows the cell experiment results of the relative gene expression level (6 hours) of cashew nut membrane extract.

[0031] Fig.15 The bar graph shows the cell experiment results of the relative gene expression (24 hours) of cashew nut membrane extract.

[0032] Fig.16 The bar graph shows the cell experiment results of the relative gene expression (24 hours) of cashew nut membrane extract.

[0033] Fig.17 The bar graph shows the cell experiment results of the relative gene expression (48 hours) of cashew nut membrane extract.

[0034] Fig.18 The bar graph shows the cell experiment results of the relative gene expression (48 hours) of cashew nut membrane extract.

[0035] Fig.19 The bar graph shows the results of a human experiment on the concentration of malondialdehyde, an antioxidant indicator, in the blood at week 0, week 8, and week 12.

[0036] Fig. 20 A bar graph showing the results of a human experiment measuring hair diameters of subjects at week 0, week 8, and week 12.

[0037] Wherein, the reference numerals are:

[0038] G01: Blank group

[0039] G02: Control group

[0040] G30~G46: Experimental group

[0041] P1~P14: Separation section DETAILED DESCRIPTION

[0042] The following describes some specific implementations of the present invention. Without departing from the spirit of the present invention, the present invention can be implemented in a variety of different forms, and the scope of protection should not be limited to the conditions specifically stated in the specification.

[0043] In some embodiments, the cashew nut membrane extract is obtained by subjecting the cashew nut membrane to an extraction process.

[0044] In some embodiments, the cashew membrane to be extracted is cashew kernel membrane (also known as cashew seed coat, cashew skin). Cashew kernel membrane is one or a combination of the thin film, membrane, outer skin or seed shell inside the cashew fruit, hereinafter referred to as cashew membrane.

[0045] In some embodiments, in the extraction process, the cashew nut membrane to be extracted may be a raw material (e.g., a complete cashew nut membrane), or may be physically pre-treated to be broken down into small-sized forms such as fragments, granules, or powder. The physical pre-treatment used may include at least one of the following: coarse crushing, chopping, shearing, pounding, and grinding.

[0046] In some embodiments, the solvent may be water, alcohol or a combination thereof. In the extraction procedure, the cashew nut membrane is extracted with a solvent at 80° C. to 90° C. for 80 to 120 minutes to obtain a primary extract. For example, the cashew nut membrane may be soaked in water at 85±5° C. for 90 minutes to dissolve the active ingredients of the cashew nut membrane into the solvent to obtain a primary extract.

[0047] In some embodiments, during the extraction process, the weight ratio of cashew nut membrane to solvent is 5 to 20: 1 to 5. For example, the weight ratio of cashew nut membrane to water is 10:1.

[0048] In some embodiments, during the extraction process, the primary extract can be further filtered to remove the cashew membrane and other solids extracted by the solvent to obtain a cashew membrane filtrate. For example, the primary extract is filtered using a 400 mesh filter to remove fine solids. The filtered cashew membrane filtrate is then heated at 60°C ± 5°C and heated at 1 ± 0.2 kg / cm 2 The cashew nut membrane concentrate is concentrated under reduced pressure under steam until the Brix value of the solution is 8.8±0.5, and then the concentration is stopped to obtain a cashew nut membrane concentrate. If the pH value of the obtained cashew nut membrane concentrate is higher than 4.0, 0.23% malic acid can be added to reduce the pH value to 3.2±0.5 to obtain a cashew nut membrane extract.

[0049] In some embodiments, the cashew nut membrane extract can be at least one embodiment or combination thereof including a primary extract, a cashew nut membrane filtrate, a cashew nut membrane concentrate, or a cashew nut membrane extract adjusted with malic acid.

[0050] In some embodiments, cashew nut membrane extract can reduce the concentration of malondialdehyde (MDA) in the blood of an organism. The concentration of malondialdehyde in the blood of an organism is a product of peroxidation of cell lipids attacked by free radicals; if more malondialdehyde accumulates in the body, it means that the body's antioxidant capacity is poor. Specifically, cashew nut membrane extract can reduce the concentration of MDA in the blood, thereby improving the body's antioxidant capacity. Therefore, cashew nut membrane extract is suitable for preparing a biological composition with antioxidant properties.

[0051] In some embodiments, the aforementioned organism may be a human.

[0052] In some embodiments, cashew nut membrane extract can reduce ROS (reactive oxygen species) in the body to reduce hair follicle cell damage. An appropriate level of ROS is necessary for the normal function of cells, but excessive ROS will produce oxidative stress on hair follicle cells, leading to cell damage and apoptosis, affecting the normal function of hair follicles, and thus may affect the hair growth cycle and hair health. Therefore, cashew nut membrane extract is suitable for preparing a composition for reducing hair follicle cell damage.

[0053] In some embodiments, a person skilled in the art can draw some correlation conclusions by analyzing the concentration of malondialdehyde in the blood of an organism and the reduction of ROS in the organism: cashew nut membrane extract improves the antioxidant capacity of the organism, and cashew nut membrane extract improves the antioxidant capacity of hair follicle cells. In other words, cashew nut membrane extract can be used to prepare a hair care composition that improves the antioxidant capacity of hair follicle cells in an organism.

[0054] In some embodiments, cashew membrane extract has the function of improving hair follicle health. Improving hair follicle health is by reducing hair follicle cell damage, increasing hair follicle cell proliferation, or a combination thereof. Wherein, the cashew membrane extract is a compound separated from the cashew membrane extract, and the compound comprises at least one compound or a combination of epicatechin coumarate, phloroglucinol, protocatechuic acid, or naringenin 7-O-(6"-O-p-coumaryl)-β-D-glucoside.

[0055] In some embodiments, the compound of the cashew nut membrane extract is gallic acid, gallocatechin, epicatechin gallate, epicatechin coumarate, phloroglucinol, protocatechuic acid, or naringenin 7-O-(6″-O-p-coumaryl)-β-D-glucoside.

[0056] The causes of hair loss include internal and external factors. External factors include lifestyle factors, such as stress, irregular lifestyle, drug effects, diseases such as thyroid problems, and dietary environmental factors, such as malnutrition or insufficient intake, and even hairdressing behaviors such as perming and dyeing may also cause hair problems. Internal factors mainly include genetic genes, the influence of dihydrotestosterone (DHT), and local microcirculation problems. Genetic genes make scalp hair follicles more sensitive to hormones, and DHT may cause hair loss for some hair follicles. At the same time, poor blood circulation may also cause hair to fall due to insufficient nutrition. In some embodiments, cashew nut membrane extract has the function of improving hair follicle health to improve hair loss caused by internal factors. For example, improving hair follicle health is to reduce hair follicle cell damage, increase hair follicle cell proliferation, increase hair follicle angiogenesis, promote hair growth gene expression, or reduce hair loss gene expression, or one or a combination thereof. Therefore, cashew nut membrane extract is suitable for preparing a composition for hair care.

[0057] In some embodiments, cashew nut membrane extract can effectively increase the expression of angiogenesis genes in hair follicle cells, and the angiogenesis gene can be a VEGF gene (vascular endothelial growth factor). The protein encoded by the VEGF gene can bind to the receptor (VEGF receptor, VEGFR) on the surface of vascular endothelial cells, and then promote the process of angiogenesis by activating multiple signal transduction pathways such as intracellular tyrosine kinase, including but not limited to the PI3K-Akt pathway, Ras-Raf-MEK-ERK pathway and Src kinase pathway, thereby achieving the effect of promoting the delivery of hair growth nutrients. Specifically, because the health and vitality of hair follicle cells are closely related to the supply of surrounding blood vessels, and the expression of angiogenesis genes is related to the formation and proliferation of blood vessels. Cashew nut membrane extract has the ability to increase the expression of VEGF gene by about 1.26 times, thereby increasing the expression of angiogenesis-related genes in hair follicle cells, promoting the proliferation and development of surrounding blood vessels, and improving the ability of blood vessels to transport nutrients, so that hair follicle cells obtain more nutrients, and promote hair growth and health. Therefore, cashew nut membrane extract is suitable for preparing a hair care composition that increases hair follicle angiogenesis.

[0058] In some embodiments, cashew membrane extract can effectively increase the expression of angiogenesis genes in hair follicle cells, and the angiogenesis gene can be the IGF-1 gene. The protein encoded by the IGF-1 gene can bind to the receptors (IGF-1R (Insulin-like Growth Factor 1 Receptor) or IR (Insulin Receptor)) on the surface of vascular endothelial cells, and then promote the process of angiogenesis by activating multiple signal transduction pathways such as intracellular tyrosine kinase, including but not limited to the PI3K-Akt pathway, Ras-Raf-MEK-ERK pathway and Src kinase pathway, thereby achieving the effect of promoting the delivery of hair growth nutrients. Specifically, because the health and vitality of hair follicle cells are closely related to the supply of surrounding blood vessels, and the expression of angiogenesis genes is related to vasodilation and vascular resistance. Cashew membrane extract has the ability to increase the expression of IGF-1 gene by about 1.5 times, thereby increasing the expression of angiogenesis-related genes in hair follicle cells, promoting peripheral vasodilation, reducing vascular resistance, and improving the ability of blood vessels to transport nutrients, so that hair follicle cells can obtain more nutrients and promote hair growth and health. Therefore, the cashew nut membrane extract is suitable for preparing a hair care composition for increasing hair follicle angiogenesis.

[0059] In some embodiments, cashew membrane extract can effectively promote the expression of hair growth genes, and the hair growth gene can be the KROX20 gene. The protein encoded by the KROX20 gene regulates the hair follicle development process, including but not limited to regulating the hair cycle, controlling the production of hair pigments, and promoting the formation of hair follicles. Cashew membrane extract has the ability to increase the expression of the KROX20 gene by about 1.93 times, thereby increasing the expression of hair growth-related genes in hair follicle cells. Therefore, cashew membrane extract is suitable for preparing a composition for hair care that promotes hair growth genes.

[0060] In some embodiments, cashew nut membrane extract can effectively promote the expression of hair growth genes, and the hair growth gene can be the SCF gene. The protein encoded by the SCF gene is a cytokine called hematopoietic stem cell factor (Stem Cell Factor, referred to as SCF). SCF plays an important physiological role in multiple tissues and organs, including the regulation of hair growth and hair follicle function. Cashew nut membrane extract has the ability to increase the expression of the SCF gene by about 1.08 times, thereby increasing the expression of hair growth-related genes in hair follicle cells. Therefore, cashew nut membrane extract is suitable for preparing a composition for hair care that promotes hair growth genes.

[0061] In some embodiments, cashew membrane extract can effectively inhibit the expression of hair loss genes, and the hair loss genes can be SRD5α1, SRD5α2, or a combination thereof. The 5α-reductase encoded by the SRD5α1 gene and the SRD5α2 gene participates in the metabolic process of androgens, including the conversion of testosterone into more active dihydrotestosterone; excessive dihydrotestosterone is related to androgen-related intrinsic factors of hair loss (such as male pattern baldness). The effect of dihydrotestosterone on hair follicles may cause apoptosis of hair and shorten the growth cycle, thereby inhibiting the growth of hair follicles, and also promoting the secretion of oil by sebaceous glands, leading to hair loss and oily scalp. Cashew membrane extract has the ability to inhibit the SRD5α1 gene by about 0.75 times and the ability to inhibit the SRD5α2 gene by about 0.68 times, thereby reducing the expression of hair loss genes to increase the health of hair follicles. Therefore, cashew membrane extract is suitable for preparing a hair care composition that reduces hair loss genes.

[0062] In some embodiments, cashew nut membrane extract can effectively inhibit the expression of hair loss genes, and the hair loss gene can be AR (Androgen receptor gene). Highly active AR combined with excessive dihydrotestosterone may aggravate the effect of androgen on hair follicles, resulting in the inhibition of hair follicle growth, thereby inhibiting hair follicle growth. Cashew nut membrane extract has the ability to inhibit the AR gene by about 0.8 times, thereby reducing the expression of hair loss genes to increase hair follicle health. Therefore, cashew nut membrane extract is suitable for preparing a hair care composition that reduces hair loss genes.

[0063] In some embodiments, cashew membrane extract can effectively inhibit the expression of hair loss genes, and the hair loss gene can be TGF-β gene (encoding transforming growth factor-β). TGF-β gene will inhibit hair growth, promote inflammation, and cause hair loss and scalp inflammation under certain conditions, and the certain conditions may be but are not limited to changes in androgen levels. Cashew membrane extract has the ability to inhibit TGF-β gene by about 0.87 times, thereby reducing the expression of hair loss genes to increase hair follicle health. Therefore, cashew membrane extract is suitable for preparing a hair care composition that reduces hair loss genes.

[0064] In some embodiments, cashew nut membrane extract is used to prepare a composition for hair health. For example, the composition can be in the form of a powdered capsule containing cashew nut membrane extract, or a drink containing liquid cashew nut membrane extract. In some embodiments, a composition comprises a container and a cashew nut membrane extract contained in the container. For example, the cashew nut membrane extract drink is a cashew beverage containing cashew nut membrane extract in the container.

[0065] In some embodiments, the aforementioned composition can be manufactured into enteral, parenteral, or oral dosage forms using techniques well known to those skilled in the art.

[0066] In some embodiments, enteral or oral administration may be, but is not limited to, tablets, troches, lozenges, pills, capsules, dispersible powders, granules, solutions, suspensions, emulsions, syrups, elixirs, slurries, or the like.

[0067] In some embodiments, when the aforementioned composition is an edible composition, the edible composition comprises a specific amount of cashew nut membrane extract, wherein the edible composition can be in the form of powder, granules, solution, colloid or paste.

[0068] In some embodiments, the edible composition containing the cashew nut membrane extract may be a food product or a food additive.

[0069] In some embodiments, the edible composition containing cashew nut membrane extract may be beverages, fermented foods, bakery products, health foods or dietary supplements. In some embodiments, the edible composition containing cashew nut membrane extract may further include an adjuvant. For example, the adjuvant may be maltodextrin, malic acid, sucralose, citric acid, fruit flavor, honey flavor, steviol glycoside or a combination thereof. The type and amount of the selected adjuvant are within the professional accomplishment and routine technical scope of ordinary technicians in the field.

[0070] In some embodiments, the food additive may be a seasoning, a sweetener, a flavoring, a pH adjuster, an emulsifier, a coloring agent, a stabilizer, or the like.

[0071] In some embodiments, in the aforementioned composition, the daily intake of cashew nut membrane extract is 4 grams of liquid.

[0072] Unless otherwise specified in the following examples, the experimental steps were performed at room temperature (25℃-30℃) and atmospheric pressure (1atm). In the following examples, Excel software was used for statistical analysis. Data are expressed as mean ± standard deviation (SD), and the differences between groups were analyzed by student's t-test. In the figure, "*" represents p value less than 0.05, "**" represents p value less than 0.01, and "***" represents p value less than 0.001. The more "*", the more significant the statistical difference.

[0073] Example 1: Preparation of cashew nut membrane extract

[0074] A. Materials:

[0075] 1. Cashew nut film (Origin: Vietnam).

[0076] 2. Secondary water, also known as RO water (Reverse Osmosis) or double distilled water, hereinafter referred to as "water".

[0077] B. Preparation process:

[0078] 1. After heating water to 85±5℃, cashew nut membrane is added and soaked in water at 85±5℃ for 90 minutes to form a primary extract containing solids. Here, the weight ratio of the cashew nut membrane to water is 1:10.

[0079] 2. Filter the cooled primary extract through a 400-mesh filter to remove the solids (i.e. the extracted cashew membrane) to obtain cashew membrane filtrate.

[0080] 3. After setting the temperature of the concentrator (model: Rotavapor R-100; brand: BUCHI) to 60±5°C, the filtrate is concentrated under reduced pressure using the concentrator. When the Brix value of the filtrate is concentrated to 8.8±0.5°Bx, the concentration is stopped to obtain the cashew nut membrane concentrate.

[0081] 4. Add 0.23% malic acid to the cashew nut membrane concentrate to adjust the pH value of the cashew nut membrane concentrate to pH 3.2±0.5 to obtain a cashew nut membrane extract.

[0082] Example 2: Compound analysis test

[0083] A. Materials and Instruments:

[0084] 1. Nuclear Magnetic Resonance Spectrometer (NMR): 1D and 2D spectra were obtained using Ascend 400 MHz, purchased from Bruker Co., Germany. Chemical shift is expressed in δ (ppm).

[0085] 2. High-resolution liquid chromatography mass spectrometer: Measured by connecting an ultra-high performance liquid chromatograph (Ultimate 3000 HPLC, purchased from Thermo Fisher Scientific) and a high-resolution orbital ion trap mass spectrometer (Q-EXACTIVE System with Ion Max Source, purchased from Thermo Fisher Scientific). The unit is m / z.

[0086] 3. Medium pressure liquid chromatography (MPLC): CombiFlash® Rf+, purchased from Teledyne ISCO, Lincoln, NE, USA.

[0087] 4. High Performance Liquid Chromatography (HPLC): High Performance Liquid Chromatography (HPLC) is a Hitachi chromaster 5260 series; the elution solvent delivery is a Hitachi chromaster 5110; the column thermostat is a Hitachi chromaster 5310; the diode array detector (DAD) is a Hitachi chromaster 5430, and the detection wavelength is 280 nm.

[0088] 5. HPLC analysis column: Mightysil RP-18 GP 250 (250 x 4.6 mm, 5 μm, purchased from Kanto, Tokyo, Japan).

[0089] 6. Column Chromatography Filling Materials:

[0090] (1) Macroporous resin: Diaion HP-20, purchased from Mitsubishi Chemical Corporation, Japan.

[0091] (2) Normal phase silica gel: Merck Kieselgel 60, 40-63 um, purchased from Merck, Germany, product number Art.9385.

[0092] (3) Reverse phase silica gel: Merck LiChroprep® RP-18, 40-63 um, purchased from Merck, Germany, product number Art. 0250.

[0093] 7. Thin-Layer Chromatography:

[0094] (1) Normal phase TLC aluminum sheet: Thin layer chromatography sheet, coated with silica gel 60 F 254 (0.25 mm), purchased from Merck, Germany.

[0095] (2) Reverse phase TLC aluminum sheet: Thin layer chromatography sheet, coated with RP-18 F 254-S (0.25 mm), purchased from Merck, Germany.

[0096] 8. UV Lamp: UVP UVGL-25, wavelength is 254 nm and 365 nm.

[0097] 9. Solvents: Methanol, n-butanol, methanol-d4 (deuterated 99.5%), deuterium oxide (deuterated > 99.8%), and dimethyl sulfoxide-d6 (deuterated > 99.9%) were purchased from Merck, Taiwan, China.

[0098] 10. Filter membrane: Polyvinylidene fluoride membrane filters (PVDF), pore size 0.22 μm, purchased from Millipore, USA.

[0099] 11. Sample: Cashew nut membrane extract prepared in Example 1.

[0100] B. Compound separation and structure identification process:

[0101] 1. Using n-butanol as solvent, 5 liters of cashew nut membrane extract prepared in Example 1 was subjected to liquid-liquid partition extraction to obtain 48.9 grams of n-butanol soluble part (fat-soluble component) and 156.3 grams of water-soluble part (water-soluble component), thereby separating the fat-soluble component and the water-soluble component of the cashew nut membrane extract obtained in Example 1. During the separation and purification process, the bioassay guided fractionation method was adopted.

[0102] 2. Take 40 g of the n-butanol soluble portion from step 1 and continue to perform preliminary separation using Diaion HP-20 macroporous resin column chromatography, using pure water, pure water-methanol volume ratio 1:1, and methanol 5 liters each as the eluent to obtain three separation portions (hereinafter referred to as the first separation portion P1, the second separation portion P2, and the third separation portion P3).

[0103] 3. Take the first separation part P1 and re-separate it with reverse-medium pressure liquid chromatography (RP-MPLC) to obtain multiple eluents. Here, the eluent is linearly eluted from water to methanol, the eluent time is 60 minutes, and the flow rate is 15 ml per minute. Subsequently, reverse phase thin layer chromatography (reverse phase TLC aluminum sheet: thin layer chromatography sheet, coated with RP-18 F 254-S (0.25 mm)) and the extracts with similar results were combined to obtain three sub-separations, such as Figure 1 As shown (hereinafter referred to as the fourth separation part P4, the fifth separation part P5, and the sixth separation part P6).

[0104] 4. The fifth separation portion P5 was purified by reverse phase-high efficiency liquid chromatography (methanol / water = 1 / 19) to obtain compound TCI-CsN-01. 1 After analyzing its chemical structure by H-NMR, it was confirmed that compound TCI-CsN-01 was gallic acid. Figure 2 shown.

[0105] 5. The sixth separation portion P6 was purified by reverse phase-high performance liquid chromatography (methanol / water = 1 / 9) to obtain compounds TCI-CsN-11 and TCI-CsN-12. It was confirmed that compound TCI-CsN-11 was phloroglucinol and TCI-CsN-12 was protocatechuic acid. Figure 6 and Figure 7 shown.

[0106] 6. Take the second separation part P2 and separate it again by reverse phase medium pressure liquid chromatography (RP-MPLC) to obtain multiple eluents. Here, the eluent is linearly eluted from water to methanol, the eluent time is 100 minutes, and the flow rate is 15 ml per minute. Subsequently, by reverse phase thin layer chromatography analysis, the eluents with similar results are combined to obtain 8 sub-separation parts, such as Figure 1 As shown (hereinafter referred to as the seventh separation part P7, the eighth separation part P8, the ninth separation part P9, the tenth separation part P10, the eleventh separation part P11, the twelfth separation part P12, the thirteenth separation part P13, and the fourteenth separation part P14).

[0107] 7. The seventh separation portion P7 was purified by reverse phase-HPLC (methanol / water = 3 / 17) to obtain compound TCI-CsN-02. 1 After analyzing its chemical structure with H-NMR, it was confirmed that compound TCI-CsN-02 is gallocatechin. Figure 3 shown.

[0108] 8. The tenth fraction P10 was purified by reverse phase-HPLC (methanol / water = 3 / 7) to obtain compound TCI-CsN-07. Compound TCI-CsN-07 was confirmed to be epicatechin gallate. Figure 4 shown.

[0109] 9. The eleventh fraction P11 was purified by reverse phase-HPLC (methanol / water = 2 / 3) to obtain compound TCI-CsN-13. TCI-CsN-13 is naringenin 7-O-(6"-O-p-coumaryl)-β-D-glucoside, such as Figure 8 shown.

[0110] 10. The thirteenth separation fraction P13 was purified by reverse phase-HPLC (methanol / water = 1 / 1) to obtain compound TCI-CsN-05. 1 After analyzing its chemical structure with H-NMR, the compound TCI-CsN-05 was confirmed to be epicatechin coumarate by literature comparison. Figure 5 shown.

[0111] The names and chemical structures of the above compounds are shown in Table 1 below.

[0112] Table 1

[0113]

[0114] Example 3: Hair follicle cell antioxidant test

[0115] A. Materials and Instruments:

[0116] 1. Cell line: Human follicle dermal papilla cells (HFDPC), purchased from PromoCell, cell number C-12071, hereinafter referred to as HFDPC cells.

[0117] 2. Cell culture medium: Follicle Dermal Papilla Cell Growth Medium (purchased from PromoCell, product number C-26501).

[0118] 3. DCFH-DA reagent: It is prepared with DCFH-DA (2',7'-dichlorodihydrofluorescein diacetate) (purchased from Sigma, product number SI-D6883-50MG) and DMSO (purchased from Sigma, product number 472301).

[0119] 4. Preparation of 1X DPBS: Dilute 10X DPBS 10 times with sterile ddH2O.

[0120] 5. 100 mM H2O2 aqueous solution: Mix H2O2 and 1X DPBS at a volume ratio of 1:88 and set aside.

[0121] 6. Trypsin: Prepare by diluting 10X trypsin (purchased from Gibco, product number 15400-054) with 9 times its volume of DPBS.

[0122] 7. Flow cytometer, model BD Accuri, purchased from BD Company.

[0123] B. Test process:

[0124] 1. Plate HFDPC cells at 1 x 10 per well. 5 The cells were inoculated in a 6-well culture dish with 2 ml of cell culture medium per well and cultured at 37° C. for 24 hours. Here, HFDPC cells were divided into three experimental groups, namely: blank group G01, control group G02 and experimental group.

[0125] 2. After 24 hours of culture, each group was replaced with experimental culture medium. Among them, the experimental culture medium of the blank group G01 and the control group G02 was a cell culture medium without cashew membrane extract or its compounds, and the experimental culture medium of the experimental group was shown in Table 2 and Table 3. Then, each group was incubated at 34°C for 1 hour.

[0126] Table 2

[0127]

[0128] Table 3

[0129]

[0130] 3. After 1 hour of action, DCFH-DA action reagent was added to each group to a final concentration of 5 μg / mL, and each group was incubated at 37°C for 15 minutes.

[0131] 4. After 15 minutes of action, add 5 μl / well of 100 mM H2O2 aqueous solution and incubate at 34 o C treatment for 0.5 hours.

[0132] 5. Remove the experimental culture medium of each group after treatment and rinse twice with 1X DPBS.

[0133] 6. After rinsing, add 500 μl of trypsin to each well and react for 5 minutes in the dark. After the reaction, add cell culture medium to terminate the reaction. Then collect the suspended cells and cell culture medium in each well into the corresponding 1.5 ml microcentrifuge tube, and centrifuge at 400 xg for 5 minutes to precipitate the cells in each centrifuge tube.

[0134] 7. Remove the supernatant from each centrifuge tube, wash the precipitated cells once with 1X DPBS, and centrifuge at 400 xg for 5 minutes. Remove the supernatant from each centrifuge tube again, and add 200 μl of 1X DPBS to each centrifuge tube to resuspend the cells to form a cell suspension.

[0135] 8. After setting the excitation light parameters of the flow cytometer to 450-490 nm and the scattered light parameters to 510-550 nm, the fluorescence signal of DCFH-DA in each group was detected by flow cytometer. Since DCFH-DA will be hydrolyzed into DCFH (dichlorodihydrofluorescein) after entering HFDPC cells, and then oxidized by reactive oxygen species (ROS) into DCF (dichlorofluorescein) that can emit green fluorescence, the fluorescence intensity of HFDPC cells treated with DCFH-DA can reflect the ROS content in CCD-996SK cells, and thus the proportion of cells with high ROS expression in HFDPC cells to the original number of cells can be known.

[0136] C. Test Results:

[0137] The relative ROS generation of all groups was calculated according to the following formula: relative ROS generation (%) = (green fluorescence signal of each group / green fluorescence signal of blank group G01) × 100%.

[0138] Since the experiment was repeated three times, the measurement results of the three repeated experiments of each group were averaged to obtain the average value, and then the statistically significant differences between the experimental results of the control group G02 and the other groups were statistically analyzed by student's t-test. In the figure, "*" represents that the p value is less than 0.05 when compared with the control group G02, "**" represents that the p value is less than 0.01 when compared with the control group G02, and "***" represents that the p value is less than 0.001 when compared with the control group G02.

[0139] See also Fig. 9 . The cells of the blank group G01 were not treated with cashew membrane extract, nor were H2O2 added for stimulation. Therefore, the test results of the blank group G01 represent the performance of cells under normal physiological metabolism. Here, when the relative ROS generation of the blank group G01 was set to 100%, the relative ROS generation of the control group G02 was 180.7%; the relative ROS generation of the experimental group G30 was 65.8%, and the relative ROS generation of the experimental group G32 was 53.5%. In other words, compared with the blank group G01, the relative ROS generation of the cells of the control group G02 increased by about 80.1% after the addition of H2O2 stimulation. Compared with the control group G02, the relative ROS generation of the experimental group G30 significantly decreased by about 63.5% after adding a lower concentration of cashew membrane extract and adding H2O2 stimulation. Compared with the blank group G01, the relative ROS generation of the experimental group decreased by about 34.2% (the ROS inhibition rate is shown in Table 4 below). Compared with the control group G02, the experimental group G32 significantly reduced the relative ROS generation by about 70.4% after adding a higher concentration of cashew membrane extract and adding H2O2 stimulation. Compared with the blank group G01, the relative ROS generation of the experimental group 1 decreased by about 46.5% (ROS inhibition rate is shown in Table 4 below).

[0140] Table 4

[0141]

[0142] See also Fig.10 The cells in the blank group G01 were not treated with cashew membrane extracts, nor were they stimulated with H2O2. Therefore, the experimental results of the blank group G01 represent the performance of cells under normal physiological metabolism. The relative ROS generation of each group is shown in Figure 2. Fig.10 Here, the ROS inhibition rate (%) of each group was calculated by this formula: (ROS generation amount of control group G02-ROS generation amount of blank group G01)-(ROS generation amount of experimental group-ROS generation amount of blank group G01) ÷ (ROS generation amount of control group G02-ROS generation amount of blank group G01), and the ROS inhibition rate results of the experimental group are shown in Table 5 below.

[0143] Table 5

[0144]

[0145] It can be seen that cashew membrane extract can significantly reduce the amount of ROS generated by hair follicle cells caused by H2O2. H2O2 induces cells to undergo aerobic metabolism, thereby generating ROS. ROS in cells will attack macromolecules such as proteins, nucleic acids, and lipids, causing cell damage. In other words, the experiment proved that cashew membrane extract and its compounds have the ability to enhance the antioxidant capacity of hair follicle cells and reduce damage to hair follicle cells. Cashew membrane extract has the effect of enhancing antioxidant activity and reducing cell damage.

[0146] Example 4: Test to promote hair follicle cell proliferation

[0147] A. Materials and Instruments:

[0148] 1. Detection kit: Cell proliferation detection reagent kit (Click-iT™ Plus EdU Flow Cytometry Assay Kits-Alexa Fluor™ 488 picolyl azide, 50 tests), purchased from Invitrogen, product number C10632.

[0149] 2. Flow cytometer (purchased from BD, product number BD Accuri).

[0150] B. Test process:

[0151] 1. Plate HFDPC cells at 1×10 per well. 5 The cells were inoculated in a 6-well culture dish at a density of 100 cells / well and cultured at 5% CO2 and 37°C until the cells reached 80% to 90% confluence. Here, HFDPC cells were divided into various groups as shown in Tables 6 and 7.

[0152] Table 6

[0153]

[0154] Table 7

[0155]

[0156] 2. After 24 hours of culture, the DNA content of each group was determined using the cell proliferation detection reagent kit. Here, after treating the cells of each group according to the test flow provided by the cell proliferation detection reagent kit, the excitation light parameters of the flow cytometer were set to 450-490 nm, and the scattered light parameters were set to 510-550 nm, and the fluorescence signal of EdU (5-ethynyl-2'-deoxyuridine) of each group was detected by flow cytometer.

[0157] C. Test Results:

[0158] The DNA content of each group was used as the basis for analyzing the hair follicle cell proliferation rate of each group. The relative hair follicle cell proliferation rate of all groups was calculated according to the following formula: relative hair follicle cell proliferation rate (%) = (fluorescence signal of each group / fluorescence signal of G01 in the blank group) × 100%.

[0159] The statistically significant differences between the test results of the blank group G01 and the other groups were obtained by statistical analysis using the student's t-test. In the figure, "*" represents that the p value is less than 0.05 when compared with the blank group G01, "**" represents that the p value is less than 0.01 when compared with the blank group G01, and "***" represents that the p value is less than 0.001 when compared with the blank group G01.

[0160] See also Fig.11 . The blank group G01 was not treated with cashew membrane extract, so the test results of the blank group G01 represent the performance of HFDPC cells under normal physiological metabolism. Here, when the relative hair follicle cell proliferation rate of the blank group G01 is set to 100%, the relative hair follicle cell proliferation rate of the control group G02 is 138.8%; the relative hair follicle cell proliferation rate of the experimental group G30 is 114.6%; the relative hair follicle cell proliferation rate of the experimental group G32 is 86.9%. In other words, compared with the blank group G01, the HFDPC cells in the control group G02 significantly increased the relative hair follicle cell proliferation rate by about 38.8% after adding 20% ​​fetal bovine serum. Compared with the blank group G01, the HFDPC cells in the experimental group G30 significantly increased the relative hair follicle cell proliferation rate by about 14.6% after adding 0.125% cashew membrane extract.

[0161] See also Fig.12. The blank group G01 was not treated with cashew membrane extract, so the test results of the blank group G01 represent the performance of HFDPC cells under normal physiological metabolism. Here, when the relative hair follicle cell proliferation rate of the blank group G01 was set to 100%, the relative hair follicle cell proliferation rate of the control group G02 was 118.8%; the relative hair follicle cell proliferation rate of the experimental group G34 was 83.7%; the relative hair follicle cell proliferation rate of the experimental group G36 was 93.5%; the relative hair follicle cell proliferation rate of the experimental group G38 was 89.9%; the relative hair follicle cell proliferation rate of the experimental group G40 was 114.1%; the relative hair follicle cell proliferation rate of the experimental group G42 was 127.9%; the relative hair follicle cell proliferation rate of the experimental group G44 was 109.6%; the relative hair follicle cell proliferation rate of the experimental group G46 was 125%. That is to say, compared with the blank group G01, the HFDPC cells in the control group G02 significantly increased the relative hair follicle cell proliferation rate by about 18.8% after adding 20% ​​fetal bovine serum. Compared with the blank group G01, there was no significant difference in the experimental groups G34~38; the experimental groups G40~46 had significantly increased relative hair follicle cell proliferation rates of about 14.1%, 27.9%, 9.6% and 25%.

[0162] The experimental results show that 0.125% cashew membrane extract and experimental group G40~experimental group G46 can significantly promote the proliferation of hair follicle cells. Moreover, the proliferation effect of experimental group G42 and experimental group G46 in promoting the proliferation rate of hair follicle cells is better than that of control group G02. In other words, the experiment proves that cashew membrane extract and its compounds can promote the proliferation of hair follicle cells and promote hair growth, and thus be used for hair health care.

[0163] Example 5: Cashew nut membrane extract test on the expression of genes related to hair health

[0164] A. Materials and Instruments:

[0165] 1. RNA extraction reagent kit was purchased from Genemark.

[0166] 2. SuperScript® III reverse transcriptase, purchased from Invitrogene.

[0167] 3. ABI StepOnePlusTM Real-Time PCR system, purchased from Thermo Fisher Scientific.

[0168] 4. KAPA SYBR FAST qPCR Master Mix (2X) Kit, purchased from KAPA Biosystems, product number KK4600.

[0169] B. Test process:

[0170] HFDPC cells were cultured at 1×10 5 The cells were seeded at a density of 100 μg / mL in a 6-well culture plate with 2 mL of culture medium per well and cultured at 37°C for 24 h.

[0171] After culture, HFDPC cells were divided into several blank groups G01 and experimental groups to compare the expression of different genes. Among them, the culture medium of the blank group G01 did not contain any extract, and the culture medium of the experimental groups G30 and G32 contained 0.125% or 0.25% of the cashew membrane extract prepared in Example 1. Then, cultured at 37°C for 6 hours, 24 hours and 48 hours.

[0172] The culture medium of the blank group G01 and the experimental groups with different concentrations was removed and rinsed with PBS.

[0173] After rinsing, the cell membrane of each group of HFDPC cells was broken with the cell lysis solution of the RNA extraction reagent kit to form a cell solution.

[0174] The RNA in the cell solution of each group was extracted using an RNA extraction reagent kit.

[0175] 2000 ng of extracted RNA was used as template in each group, and the extracted RNA was reverse transcribed into corresponding cDNA using SuperScript® III reverse transcriptase.

[0176] Using ABI StepOnePlus TM Real-Time PCR system, KAPA SYBR FAST qPCR Master Mix (2X) Kit and the primer combination in Table 8 were used to perform quantitative real-time reverse transcription polymerase chain reaction on cDNA to observe the expression of various target genes and their melting curves in the blank group G01 and the experimental group HFDPC cells. The instrument setting conditions for the quantitative real-time reverse transcription polymerase chain reaction were 95°C for 20 seconds, 95°C for 3 seconds, 60°C for 30 seconds, and repeated 40 cycles.

[0177] Use 2 -ΔΔCt Methods The relative expression of the target gene was determined. The relative expression was defined as the multiple change of the RNA expression of the target gene in the experimental group relative to the RNA expression of the same gene in the blank group G01. -ΔΔCtMethods The cycle threshold of TBP gene was used as the cycle threshold (Ct) of the reference gene for internal control, and the fold change was calculated according to the following formula:

[0178] △Ct = Ct 实验组之目标基因 / 空白组G01之目标基因 – Ct GAPDH

[0179] △△Ct= △Ct 实验组之目标基因 – △Ct 空白组G01之目标基因

[0180] Fold change = 2 -ΔΔCt平均值

[0181] The standard deviation of the relative expression was calculated by STDEV in Excel. The statistically significant differences between the blank group G01 and the test results of the other groups were obtained by statistical analysis using the student's t-test. In the figure, "*" represents that the p value is less than 0.05 when compared with the blank group G01, "**" represents that the p value is less than 0.01 when compared with the blank group G01, and "***" represents that the p value is less than 0.001 when compared with the blank group G01.

[0182] Table 8 below shows the relevant sequences of the relevant gene expression experiments.

[0183] Table 8

[0184]

[0185] Here, the statistically significant difference between the measurement results of the blank group G01 and the experimental group was obtained by statistical analysis using the student's t-test. (In the figure, "*" represents that the p value is less than 0.05 when compared with the blank group G01, "**" represents that the p value is less than 0.01 when compared with the blank group G01, and "***" represents that the p value is less than 0.001 when compared with the blank group G01. The more "*" there are, the more statistically significant the difference is).

[0186] For the results of the 6-hour genetic test, please refer to Fig.13 and Fig.14. In the blank group G01, the HFDPC cells were not treated in any way, which means that they were under normal physiological metabolism, and the expression of their genes was set to 1.0. The expression of the SRD5α1 gene in the SRD5α1 gene experimental group was -0.49 times and -0.54 times that of the blank group G01, respectively. The expression of the SRD5α2 gene in the SRD5α2 gene experimental group was 3.4 times and 3.65 times that of the blank group G01. The expression of the AR gene in the AR gene experimental group was 1.04 times and 1.3 times that of the blank group G01. The expression of the KROX20 gene in the KROX20 gene experimental group was 1.93 times and 1.85 times that of the blank group G01. The expression of the SCF gene in the SCF gene experimental group was 1.08 times and 1.05 times that of the blank group G01. The expression of the VEGF gene in the VEGF gene experimental group was 1.16 times and 1.26 times that of the blank group G01. The expression level of IGF1 gene in the IGF1 gene experimental group was 1.49 times and 1.5 times that of the blank group G01. The expression level of TGF-β gene in the TGF-β gene experimental group was -0.87 times and -0.85 times that of the blank group G01.

[0187] For results of 24-hour genetic testing, please refer to Fig.15 and Fig.16 . In the blank group G01, the HFDPC cells were not treated in any way, which means that they were under normal physiological metabolism, and the expression of their genes was set to 1.0. The expression of the SRD5α1 gene in the SRD5α1 gene experimental group was -0.73 times and -0.75 times that of the blank group G01. The expression of the SRD5α2 gene in the SRD5α2 gene experimental group was 1.02 times and 1.12 times that of the blank group G01. The expression of the AR gene in the AR gene experimental group was 1.29 times and 1.43 times that of the blank group G01. The expression of the KROX20 gene in the KROX20 gene experimental group was 1.01 times and 1.04 times that of the blank group G01. The expression of the SCF gene in the SCF gene experimental group was -0.73 times and -0.665 times that of the blank group G01. The expression of the VEGF gene in the VEGF gene experimental group was -0.89 times and -0.93 times that of the blank group G01. The expression level of IGF1 gene in the IGF1 gene experimental group was -0.76 times and -0.7 times that of the blank group G01. The expression level of TGF-β gene in the TGF-β gene experimental group was -0.76 times and -0.7 times that of the blank group G01.

[0188] For the results of the 48-hour genetic test, please refer to Fig.17 and Fig.18. In the blank group G01, the HFDPC cells were not treated in any way, which means that they were under normal physiological metabolism, and the expression of their genes was set to 1.0. The expression of the SRD5α1 gene in the SRD5α1 gene experimental group was -0.75 times and -0.76 times that of the blank group G01. The expression of the SRD5α2 gene in the SRD5α2 gene experimental group was 1.2 times and -0.68 times that of the blank group G01. The expression of the AR gene in the AR gene experimental group was -0.8 times and -0.77 times that of the blank group G01. The expression of the KROX20 gene in the KROX20 gene experimental group was -0.98 times and -0.93 times that of the blank group G01. The expression of the SCF gene in the SCF gene experimental group was -0.6 times and -0.68 times that of the blank group G01. The expression of the VEGF gene in the VEGF gene experimental group was -0.77 times and -0.91 times that of the blank group G01. The expression level of IGF1 gene in the IGF1 gene experimental group was -0.72 times and -0.61 times that of the blank group G01. The expression level of TGF-β gene in the TGF-β gene experimental group was -0.8 times and -0.78 times that of the blank group G01.

[0189] The statistical differences of the hair care related genes and the blank group G01 are shown in Table 9.

[0190] Table 9

[0191]

[0192] Note: SRD5α1, SRD5α2, AR and TGF-β are genes related to hair loss; KROX20 and SCF are genes related to hair growth; VEGF and IGF1 are genes related to angiogenesis.

[0193] It can be seen that cashew nut membrane extract can significantly inhibit the expression of SRD5α1 gene, SRD5α2 gene, AR gene and TGF-β gene; significantly increase the expression of KROX20 gene and SCF gene; and significantly increase the expression of VEGF gene and IGF1 gene, indicating that cashew nut membrane extract increases hair follicle angiogenesis, promotes the delivery of hair growth nutrients, enhances hair follicle formation, and thus improves hair follicle health. It can also reduce scalp oiliness, reduce hair loss, reduce inflammation, and reduce hair loss caused by scalp inflammation, thereby improving hair follicle health.

[0194] Example 6: Human Trial - Blood Test

[0195] A. Test process:

[0196] Seven healthy adult subjects aged 20 years and above who did not take any anti-hair loss related drugs or health products orally or externally and who felt that they had hair loss were asked to take a 50 ml bottle of test drink daily for 12 consecutive weeks (i.e. 84 days). The test drink contained 4 ml of the cashew membrane extract prepared in Example 1, and the rest was water. In addition, the subjects were blood drawn at the 0th, 8th and 12th weeks to detect the changes in the concentration of malondialdehyde, an antioxidant indicator in the blood, before and after taking the cashew membrane extract.

[0197] In this embodiment, the concentration of malondialdehyde, an antioxidant indicator in the blood of the test subjects, was tested by outsourcing, and the outsourcing unit referred to the relevant blood test standards.

[0198] B. Test Results:

[0199] The statistically significant differences between the test results of Week 0, Week 8, and Week 12 were obtained by statistical analysis using the student's t-test. In the figures, "*" represents a p-value less than 0.05 compared with Week 0, "**" represents a p-value less than 0.01 compared with Week 0, and "***" represents a p-value less than 0.001 compared with Week 0.

[0200] See also Fig.19 . The blood malondialdehyde concentration of the subjects at week 0, an antioxidant index, was about 1.47 μg / mL. At week 8 (i.e., after taking cashew nut membrane extract for 8 weeks), the blood malondialdehyde concentration of the subjects significantly decreased to about 1.31 μg / mL. At week 12 (i.e., after taking cashew nut membrane extract for 12 weeks), the blood malondialdehyde concentration of the subjects decreased to about 0.95 μg / mL. In other words, compared with before taking the drug, taking cashew nut membrane extract for 8 weeks can reduce the blood malondialdehyde concentration of these subjects by 11.4%; taking cashew nut membrane extract for 12 weeks can reduce the blood malondialdehyde concentration of these subjects by 35.6%. Moreover, the proportion of people who improved reached 100%. This indicates that cashew nut membrane extract can reduce blood MDA concentration, enhance the body's antioxidant capacity, thereby reducing hair follicle cell damage and improving hair follicle health.

[0201] Example 7: Human body test - hair diameter detection

[0202] A. Test process:

[0203] Seven healthy adult subjects aged 20 years and above who did not take any anti-hair loss related drugs or health products orally or externally and who felt that they had hair loss were asked to take a bottle of 50 ml of the test drink daily for 12 consecutive weeks (i.e. 84 days). The test drink contained 4 ml of the cashew nut membrane extract prepared in Example 1, and the rest was water. In addition, the subjects underwent hair diameter tests at the 0th, 8th and 12th weeks to detect the changes in hair diameter before and after taking the cashew nut membrane extract.

[0204] This example uses the ASG-300 / API-100 scalp detector purchased from AramHuvis, South Korea, and the unit is millimeter (mm). The detection method is to take the same position on the top of the head to calculate the diameter of about 1 cm from the hair root, and measure the average value of 3-5 hairs.

[0205] B. Test Results:

[0206] The statistically significant differences between the test results of Week 0, Week 8, and Week 12 were obtained by statistical analysis using the student's t-test. In the figures, "*" represents a p-value less than 0.05 compared with Week 0, "**" represents a p-value less than 0.01 compared with Week 0, and "***" represents a p-value less than 0.001 compared with Week 0.

[0207] See also Fig. 20 . The hair diameter of the subjects at week 0 was about 0.054 mm, the hair diameter of the subjects at week 8 (i.e., after taking cashew nut membrane extract for 8 weeks), was about 0.073 mm, and the hair diameter of the subjects at week 12 (i.e., after taking cashew nut membrane extract for 12 weeks), was about 0.081 mm. In other words, compared with before taking it, taking cashew nut membrane extract for 8 weeks can significantly increase the hair diameter of these subjects by 35.2%; taking cashew nut membrane extract for 12 weeks can significantly increase the hair diameter of these subjects by 50%. Moreover, the proportion of people who improved reached 100%. It can be seen that cashew nut membrane extract can indeed increase the hair diameter of the subjects, increase hair stability, and improve the health of hair follicles.

[0208] In summary, the cashew membrane extract of any embodiment is obtained by extracting the cashew membrane with a solvent, which can be used to prepare a hair care composition, thereby providing a composition that can produce a hair care effect on an individual when applied to the individual. In other words, the aforementioned composition has the function of hair care. In some embodiments, the composition prepared from the cashew membrane extract also has one or more of the following functions: improving the antioxidant capacity of hair follicle cells, increasing hair follicle angiogenesis, promoting hair growth gene expression, reducing hair loss gene expression, and increasing hair diameter.

[0209] Of course, the present invention may have many other embodiments. Without departing from the spirit and essence of the present invention, technicians familiar with the field may make various corresponding changes and deformations based on the present invention, but these corresponding changes and deformations should all fall within the scope of protection of the claims of the present invention.

Claims

1. A use of a cashew nut (Anacardium occidentale) membrane extract for preparing a hair care composition, wherein the cashew nut membrane extract is prepared by extracting cashew nut membrane.

2. The use as claimed in claim 1, wherein in the extraction step, the solid-liquid ratio of the cashew nut membrane to the solvent is 5 to 20:1 to 5, the extraction temperature is 80° C. to 90° C., and the extraction time is 80 minutes to 120 minutes.

3. The use as claimed in claim 1, wherein the cashew nut membrane extract has the ability to increase the health of hair follicles.

4. The use as claimed in claim 3, wherein the cashew membrane extract increases the health of hair follicles by improving the antioxidant capacity of hair follicle cells.

5. The use according to claim 4, wherein the cashew nut membrane extract is at least one compound selected from the group consisting of epicatechin coumarate, phloroglucinol, protocatechuic acid and naringenin 7-O-(6"-O-p-coumaryl)-β-D-glucoside.

6. The use as claimed in claim 3, wherein the cashew membrane extract increases the health of the hair follicles by promoting the proliferation of hair follicle cells.

7. The use according to claim 6, wherein the cashew nut membrane extract is at least one compound selected from the group consisting of epicatechin coumarate, phloroglucinol, protocatechuic acid and naringenin 7-O-(6"-O-p-coumaryl)-β-D-glucoside.

8. The use as claimed in claim 3, wherein the cashew nut membrane extract increases the health of hair follicles by increasing angiogenesis of hair follicles.

9. The use as claimed in claim 3, wherein the cashew membrane extract increases the health of the hair follicles by promoting the expression of hair growth genes.

10. The use as claimed in claim 3, wherein the cashew nut membrane extract increases the health of the hair follicles by reducing the expression of hair loss genes.

11. The use as claimed in claim 3, wherein the cashew nut membrane extract increases the health of the hair follicles by reducing blood MDA concentration.

12. The use according to claim 1, wherein the cashew nut membrane extract has the ability to increase hair diameter.